These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21808962)

  • 1. Malaysia-ACute CORonary syndromes Descriptive study (ACCORD): evaluation of compliance with existing guidelines in patients with acute coronary syndrome.
    Ahmad WA; Ramesh SV; Zambahari R
    Singapore Med J; 2011 Jul; 52(7):508-11. PubMed ID: 21808962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chilean results of the international registry of risk factors and treatment of unstable angina and non ST elevation myocardial infarction: ACCORD (ACute CORonary syndrome Descriptive study)].
    Stockins B; Albornoz F; Martínez D; Campos P; Gajardo J; Lamich R; Manríquez L; Pérez V; Rojo P; Sepúlveda P; Pumarino MG; Corbalán R
    Rev Med Chil; 2011 Jan; 139(1):19-26. PubMed ID: 21526313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.
    El-Menyar A; AlHabib KF; Al-Motarreb A; Hersi A; Al Faleh H; Asaad N; Al Saif S; Almahmeed W; Sulaiman K; Amin H; Al-Lawati J; Alsheikh-Ali AA; AlQahtani A; Al-Sagheer NQ; Singh R; Al Suwaidi J
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):127-35. PubMed ID: 22257172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
    Rao RV; Goodman SG; Yan RT; Spencer FA; Fox KA; DeYoung JP; Rose B; Grondin FR; Gallo R; Gore JM; Yan AT;
    Am Heart J; 2009 Apr; 157(4):642-50.e1. PubMed ID: 19332190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry).
    Cheng CI; Chen CP; Kuan PL; Lei MH; Liau CS; Ueng KC; Wu CJ; Lai WT
    Clin Cardiol; 2010 Jun; 33(6):E40-8. PubMed ID: 20552592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
    Banihashemi B; Goodman SG; Yan RT; Welsh RC; Mehta SR; Montalescot G; Kornder JM; Wong GC; Gyenes G; Steg PG; Yan AT;
    Am Heart J; 2009 Dec; 158(6):917-24. PubMed ID: 19958857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies.
    ACCESS Investigators
    Am Heart J; 2011 Nov; 162(5):852-859.e22. PubMed ID: 22093201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet drug resistance in patients with acute coronary syndrome.
    Guha S; Sardar P; Guha P; Roy S; Mookerjee S; Chakrabarti P; Deb PK; Chaudhuri U; Deb S; Karmakar R; Dasgupta AK; Lahiri P
    Indian Heart J; 2009; 61(1):68-73. PubMed ID: 19729693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
    Denardo SJ; Davis KE; Tcheng JE
    Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
    Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
    Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
    Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Zhu B; Zhao Z; McCollam P; Anderson J; Bae JP; Fu H; Zettler M; Lenarz L
    Curr Med Res Opin; 2011 Mar; 27(3):633-41. PubMed ID: 21241206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
    Pelc-Nowicka A; Bryniarski L; Mirek-Bryniarska E; Zabojszcz M
    Kardiol Pol; 2009 Dec; 67(12):1335-41. PubMed ID: 20054764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.